Philip Morris International Inc. to Host Webcast of 2022 Virtual Annual Meeting of Shareholders
April 27 2022 - 10:00AM
Business Wire
Regulatory News:
Philip Morris International Inc. (NYSE: PM) will host a live
audio webcast of its 2022 Annual Meeting of Shareholders on
Wednesday, May 4, 2022, at 9:00 a.m. ET. The meeting will be held
in a virtual format only, including closed captioning, and can be
accessed at www.virtualshareholdermeeting.com/PMI2022.
During the meeting, André Calantzopoulos, Executive Chairman of
the Board, and Jacek Olczak, Chief Executive Officer, will address
shareholders and answer questions. Only shareholders of record with
a valid 16-digit control number will be allowed to ask a question
or make a comment.
The audio webcast may also be accessed on iOS or Android devices
by downloading PMI’s free Investor Relations Mobile Application at
www.pmi.com/irapp.
An archived copy of the webcast will be available for
approximately one year from the date of the meeting at
www.virtualshareholdermeeting.com/PMI2022.
Presentation slides and script will also be available at
www.virtualshareholdermeeting.com/PMI2022.
Philip Morris International: Delivering a Smoke-Free
Future
Philip Morris International (PMI) is a leading international
tobacco company working to deliver a smoke-free future and evolving
its portfolio for the long-term to include products outside of the
tobacco and nicotine sector. The company’s current product
portfolio primarily consists of cigarettes and smoke-free products,
including heat-not-burn, vapor and oral nicotine products, which
are sold in markets outside the U.S. Since 2008, PMI has invested
more than USD 9 billion to develop, scientifically substantiate and
commercialize innovative smoke-free products for adults who would
otherwise continue to smoke, with the goal of completely ending the
sale of cigarettes. This includes the building of world-class
scientific assessment capabilities, notably in the areas of
pre-clinical systems toxicology, clinical and behavioral research,
as well as post-market studies. The U.S. Food and Drug
Administration (FDA) has authorized the marketing of versions of
PMI’s IQOS Platform 1 devices and consumables as Modified Risk
Tobacco Products (MRTPs), finding that exposure modification orders
for these products are appropriate to promote the public health. As
of March 31, 2022, PMI's smoke-free products are available for sale
in 71 markets, and PMI estimates that approximately 12.7 million
adults around the world excluding Russia and Ukraine, have already
switched to IQOS and stopped smoking. With a strong foundation and
significant expertise in life-sciences, in February 2021 PMI
announced its ambition to expand into wellness and healthcare areas
and deliver innovative products and solutions that aim to address
unmet consumer and patient needs. For more information, please
visit www.pmi.com and www.pmiscience.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220427005512/en/
Philip Morris International
Investor Relations: New York: +1 (917) 663 2233 Lausanne: +41
(0)58 242 4666 Email: InvestorRelations@pmi.com
Media: David Fraser Lausanne: +41 (0)58 242 4500 Email:
David.Fraser@pmi.com
Philip Morris (NYSE:PM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Philip Morris (NYSE:PM)
Historical Stock Chart
From Apr 2023 to Apr 2024